Circulating Tumor DNA
38
14
14
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 38 trials
100.0%
+13.5% vs benchmark
3%
1 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (38)
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
Danish Vulva Cancer Recurrence Study
CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer
NSCLC Liquid Biopsies and Exhaled VOC
Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection
Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer
Using ctDNA to Determine Therapies for Lung Cancer
ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial
Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients
Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases
Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.
Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology
Dynamic Monitoring of ctDNA Methylation to Predict Relapse in Colorectal Cancer After Radical Resection (POSTCA)
ctDNA Methylation for Epithelial Ovarian Cancer
ctDNA Methylation for Detecting Ovarian Cancer
OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer -
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.